DOI: 10.1055/s-00025479

Experimental and Clinical Endocrinology & Diabetes Reports


Neggers SJ, de Herder WW, Janssen JA. et al.
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: Long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients.

Eur J Endocrinol 2009;
160: 529-533

Download Bibliographical Data

Search in: